Human medicines European public assessment report (EPAR): Filspari, sparsentan, Date of authorisation: 19/04/2024, Revision: 3, Status: Authorised
Committee for Medicinal Products for Human Use (CHMP): 08-11 December 2025, European Medicines Agency, Amsterdam, the Netherlands, from 8 December 2025 to 11 December 2025
Annex to agenda of the CHMP meeting 8-11 December 2025
Agenda of the CHMP meeting 8-11 December 2025
Classification of changes (tracked changes)
Classification of changes
Release notes - production release version 1.7.2544 - 5 December 2025 - Veterinary Medicinal Products Regulation: Union Product Database
Human medicines European public assessment report (EPAR): Lyfnua, gefapixant, Date of authorisation: 15/09/2023, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Eucreas, vildagliptin,metformin, Date of authorisation: 14/11/2007, Revision: 27, Status: Authorised
EMA/PE/0000224486